S051 Complications of Cosmetic Procedures
DESCRIPTION
A significant number of cosmetic procedures are currently performed by dermatologists on daily bases. The earliest diagnose is crucial for an effective management of any complication. Complications can vary from bad cosmetic results to the severe complications, such as embolism, blindness and/or disfiguring scars. This session aims to discuss complications and share knowledge on their management.
LEARNING OBJECTIVES
Manage the most important complications that may arise from frequent cosmetic procedures.
Identify the earlier signs and symptoms of most important complications of cosmetic procedures.
Effectively treat complications of the most frequent cosmetic procedures.
SCHEDULE
9:00 AM
Welcome words
Marcia Ramos-e-Silva, MD, PhD, IFAAD
DIRECTOR
Doris M Hexsel, MD, IFAAD
CO-DIRECTOR
Marcia Ramos-e-Silva, MD, PhD, IFAAD
SPEAKERS
Fernanda Cavallieri
Hassan I. Galadari, MD, FAAD
Michael H. Gold, MD, FAAD
Mayra Ianhez, MD
Joely Kaufman, MD, FAAD
Gabriela Helena Munhoz da Fontoura
Gisele Viana Oliveira, MD, MSc, PhD, IFAAD
Nuno E. Osorio, MD, IFAAD
Maria Fernanda C. Tembra, MD, IFAAD
Carlos G. Wambier, MD, FAAD
DISCLOSURES
Fernanda Cavallieri
Merz Asia Pacific Pte Ltd – Advisory Board(Fees);
Hassan I. Galadari, MD, FAAD
No financial relationships exist with ineligible companies.
Michael H. Gold, MD, FAAD
Acclaro Medical – Consultant (1099 relationship)(Honoraria); Aerolase – Stockholder(Honoraria); Aesthetic Management Partners – Consultant (1099 relationship)(Honoraria); Aesthetics Biomedical – Consultant (1099 relationship)(Honoraria); Alastin Skincare, Inc – Consultant (1099 relationship)(Honoraria); Allergan, Inc – Consultant(Honoraria); Alma Lasers – Speaker(Honoraria); Bausch Health – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Benev – Consultant (1099 relationship)(Honoraria); Cutera, Inc. – Speaker(Honoraria); EndyMed Medical Inc. USA – Speaker(Honoraria); Galderma – Consultant (1099 relationship)(Honoraria); Hugel – Consultant (1099 relationship)(Honoraria); InMode – Consultant (1099 relationship)(Honoraria); La Mer – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Investigator(Grants/Research Funding); Lumenis – Speaker(Honoraria); Merz Pharmaceuticals, LLC – Speaker(Honoraria); Mindera – Consultant (1099 relationship)(Honoraria); MTF Biologics – Consultant (1099 relationship)(Honoraria); Nutrafol – Consultant (1099 relationship)(Honoraria); Pierre Fabre – Consultant (1099 relationship)(Honoraria); Prescriber's Choice – Consultant (1099 relationship)(Honoraria); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Revision Skincare – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Rohrer Aesthetics – Consultant (1099 relationship)(Honoraria); Sciton Inc. – Consultant (1099 relationship)(Honoraria); Sensus Healthcare – Consultant (1099 relationship)(Honoraria); Sente Labs – Consultant (1099 relationship)(Honoraria); SkinBetter Science – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); SkinCeuticals LLC – Consultant (1099 relationship)(Honoraria); SkinMedica, Inc. – Consultant (1099 relationship)(Honoraria); Sofwave – Consultant (1099 relationship)(Honoraria); Stratapharma – Consultant (1099 relationship)(Honoraria); Venus Concept – Consultant(Stock Options), Speaker(Honoraria); VIOL – Consultant (1099 relationship)(Honoraria);
Doris M Hexsel, MD, IFAAD
No financial relationships exist with ineligible companies.
Mayra Ianhez, MD
AbbVie – Advisory Board(Fees), Speaker(Fees); Galderma Brasil Ltda – Advisory Board(Fees), Speaker(Fees); Janssen Pharmaceuticals, Inc – Advisory Board(Fees), Speaker(Fees); Pfizer Inc. – Advisory Board(Fees), Speaker(Fees); Sanofi Genzyme – Advisory Board(Fees), Speaker(Fees);
Joely Kaufman, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Alphaeon – Stockholder(No Compensation Received); Galderma USA – Advisory Board(Honoraria), Investigator(Fees); Jetema – Investigator(Grants/Research Funding); Johnson and Johnson – Investigator(Grants/Research Funding); L'Oreal – Investigator(Grants/Research Funding); Merz Pharmaceuticals, LLC – Investigator(Grants/Research Funding); Neutrogena Corporation – Advisory Board(Honoraria); OneSkin – Consultant (1099 relationship)(Honoraria); Revance Therapeutics, Inc. – Investigator(Fees); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Fees);
Gabriela Helena Munhoz da Fontoura
No financial relationships exist with ineligible companies.
Gisele Viana Oliveira, MD, MSc, PhD, IFAAD
No financial relationships exist with ineligible companies.
Nuno E. Osorio, MD, IFAAD
No financial relationships exist with ineligible companies.
Marcia Ramos-e-Silva, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
Maria Fernanda C. Tembra, MD, IFAAD
No financial relationships exist with ineligible companies.
Carlos G. Wambier, MD, FAAD
Allergan, Inc. – Advisory Board(Fees); Applied Biology – Advisory Board(Fees); ChemistryRx – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Cynosure – Speaker/Faculty Education(Fees); Daniel Alain – Advisory Board(Fees); Eli Lilly – Investigator(Grants/Research Funding); Galderma Brasil Ltda – Speaker(Fees); Incyte – Advisory Board(Fees); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Fees); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); UCB – Investigator(Grants/Research Funding); Wambier Dermatologics, LLC – Founder(Other Financial Benefit); Young Pharmaceuticals – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights);